← Leaderboards
Michael R Bishop
Basic Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Basic Sciences
Same institution · by research overlap
- John Janik$0
- Robert Kreitman$0
- Suresh Ambudkar$56,413
Others in their field
Top investigators on “Allogenic”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Mary M Horowitz · Medical College Of Wisconsin$47,632,939
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$40,815,122
- Marcel R M Van Den Brink · Sloan-Kettering Institute For Cancer Res$39,678,762
- Bruce R. Blazar · University Of Minnesota$37,193,531
- Megan Sykes · Columbia University Health Sciences$33,587,479
Research focus
AllogenicRelapseHematopoietic Stem Cell TransplantationProgramsGraft-Vs-Host DiseaseGraft-Versus-Tumor InductionTransplantationMinorityLymphocyteBiologyUnited States National Institutes Of HealthClinical TrialsResponseImmuneResourcesProtocols DocumentationDesignMediatingRelative (Related Person)CollaborationsConditioningPre-ClinicalCell CountBase
Grant awards (13)
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT$100,848
ZIA · FY2011 · CA · contact PI
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation$75,636
ZIA · FY2011 · CA · contact PI
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT$75,636
ZIA · FY2011 · CA · contact PI
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT$320,849
ZIA · FY2010 · CA · contact PI
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT$240,637
ZIA · FY2010 · CA · contact PI
Relapse after Allogeneci Hematopoietic Stem Cell Transplantation$240,637
ZIA · FY2010 · CA · contact PI
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT$303,626
ZIA · FY2009 · CA · contact PI
Relapse after Allogeneci Hematopoietic Stem Cell Transplantation$227,719
ZIA · FY2009 · CA · contact PI
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT$227,719
ZIA · FY2009 · CA · contact PI
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT$309,171
Z01 · FY2008 · CA · contact PI
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT$689,605
Z01 · FY2007 · CA · contact PI
Developing Immunoablative Regimens for the Engraftment o$0
Z01 · FY2006 · BC · contact PI
Development of Immunoablative Conditioning Regimens for$0
Z01 · FY2005 · BC